QNCX   $0.8200000000000001  3.42% Market Closed

Quince Therapeutics Inc
Total Cash 59.45M
totalCashPerShare 1.374
EBITDA -29.13M
Total Debt 14.38M
quickRatio 5.853
currentRatio 6.146
Total Revenue
debtToEquity 30.619
Revenue/Share
ROA -0.16496
ROE -0.79376
grossProfits
freeCashflow -7.84M
operatingCashflow -27.99M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -9.62M
forwardPE
floatShares 34.60M
sharesOutstanding 43.28M
sharesShort 1.92M
sharesShortPriorMonth 2.08M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.25%
Short Ratio help_outline 20.83%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.085
Price To Book help_outline 0.75
earningsQuarterlyGrowth
netIncomeToCommon -53.12M
trailingEps -1.33%
forwardEps -3.01%
enterpriseToEbitda 0.33
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 55
lastUpdated Oct. 17, 2024, 9:24 a.m.